Advertisement
Biology
Subscribe to Biology
View Sample

FREE Email Newsletter

ALS progression linked to increased protein instability

October 14, 2014 8:14 am | by Jon Weiner, Lawrence Berkeley National Laboratory | News | Comments

A new study by scientists from The Scripps Research Institute, Lawrence Berkeley National Laboratory and other institutions suggests a cause of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The team's work supports a common theme whereby loss of protein stability leads to disease.

All that glitters is...slimy? Gold nanoparticles measure snot stickiness

October 13, 2014 10:40 am | News | Comments

Some people might consider mucus an icky bodily secretion best left wrapped in a tissue, but to a group of researchers in North Carolina, snot is an endlessly fascinating subject. The team has developed a way to use gold nanoparticles and light to measure the stickiness of the slimy substance that lines our airways. The new method could help doctors better monitor and treat lung diseases such as cystic fibrosis.

Scientists create mimic of “good” cholesterol to fight heart disease, stroke

October 13, 2014 10:28 am | News | Comments

Researchers at The Scripps Research Institute have created a synthetic molecule that mimics “good” cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, improved cholesterol in just two weeks.

Advertisement

DNA’s security system unveiled

October 13, 2014 9:04 am | by Bill Hathaway, Yale Univ. | Videos | Comments

As befitting life’s blueprint, DNA is surrounded by an elaborate security system that assures crucial information is imparted without error. The security is provided by a double membrane perforated by protein channels that block unwanted material from entering the nucleus and promote entry of key messengers.

What to do about the dwindling stock of antibiotics

October 13, 2014 8:57 am | by Diana Lutz, Washington Univ. in St. Louis | News | Comments

The Centers for Disease Control and Prevention has said that at least 2 million Americans are sickened by antibiotic resistant infections each year and survive. Twenty-three thousand die. These experiences leave deep impressions not just on the patients but on their family and friends.

Can all U.S. hospitals safely treat Ebola?

October 13, 2014 4:38 am | by Marilynn Marchione - AP Chief Medical Writer - Associated Press | News | Comments

A breach of infection control resulting in a Dallas health worker getting Ebola raises fresh questions about whether hospitals truly can safely take care of people with the deadly virus, as health officials insist is possible. Even in the U.S., with the best conditions and protective gear available, mistakes can happen that expose more people to Ebola, the new case reveals.

Autism as a disorder of prediction

October 10, 2014 11:13 am | by Anne Trafton, MIT News Office | News | Comments

Autism is characterized by many different symptoms: difficulty interacting with others, repetitive behaviors and hypersensitivity to sound and other stimuli. Massachusetts Institute of Technology neuroscientists have put forth a new hypothesis that accounts for these behaviors and may provide a neurological foundation for many of the disparate features of the disorder.

Molecular structure of Hep C envelope protein unveiled

October 10, 2014 9:09 am | by Laura Mgrdichian, Brookhaven National Laboratory | News | Comments

Hepatitis C, an infectious disease of the liver caused by the hepatitis C virus (HCV), affects 160 million people worldwide. There’s no vaccine for HCV and the few treatments that are available do not work on all variants of the virus. Before scientists can develop potential vaccines and additional therapies they must first thoroughly understand the molecular-level activity that takes place when the virus infects a host cell.

Advertisement

DNA nanofoundries cast custom-shaped metal nanoparticles

October 10, 2014 7:50 am | by Kat J. McAlpine, Wyss Institute for Biologically Inspired Engineering | News | Comments

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard Univ. have unveiled a new method to form tiny 3-D metal nanoparticles in prescribed shapes and dimensions using DNA, nature's building block, as a construction mold. The ability to mold inorganic nanoparticles out of materials such as gold and silver in precisely designed 3-D shapes is a significant breakthrough.

Researchers capture images of elusive protein HIV uses to infect cells

October 9, 2014 11:00 am | by Bill Hathaway, Yale Univ. | News | Comments

HIV is adept at eluding immune system responses because the protein it uses to infect cells is constantly changing. Now a team of researchers including scientists from Yale Univ. have stripped the cloak from this master of disguise, providing a high-resolution image of this surface spike protein and monitoring how it constantly changes its shape, information that suggests new ways to attack the virus through drugs and vaccines.

“Cyberwar” against cancer gets boost from intelligent nanocarriers

October 9, 2014 10:48 am | News | Comments

New research involving scientists in the U.S. and Israel offers new insight into the lethal interaction between cancer cells and the immune system's communications network. The study authors devised a new computer program that models a specific channel of cell-to-cell communication involving exosomes that both cancer and immune cells harness to communicate with other cells. This “cyberwarfare” model reveals three distinct states of cancer.

New weapons against multi-drug resistance in tuberculosis

October 9, 2014 8:51 am | by Nik Papageorgiou, EPFL | News | Comments

Tuberculosis is caused by a bacterium that infects the lungs of an estimated 8.6 million people worldwide. The fight against the disease is hampered by the fact that treatment requires a long time and that the bacterium often develops multi-drug resistance. Scientists have used a sensitive screening assay to test new compounds that can be used against the bacterium, and have discovered two small molecules that show remarkable promise.

New way to extract bone-making cells from fat tissue

October 9, 2014 8:23 am | by David Orenstein, Brown Univ. | News | Comments

Within our fat lives a variety of cells with the potential to become bone, cartilage or more fat if properly prompted. This makes adipose tissue, in theory, a readily available reservoir for regenerative therapies such as bone healing if doctors can get enough of those cells and compel them to produce bone. In a new study, scientists demonstrate a new method for extracting a wide variety of potential bone-producing cells from human fat.

Advertisement

Technology that controls brain cells with radio waves earns early BRAIN grant

October 8, 2014 12:30 pm | News | Comments

A proposal to develop a new way to remotely control brain cells from Sarah Stanley, a research associate in Rockefeller Univ.’s Laboratory of Molecular Genetics is among the first to receive funding from President Barack Obama’s BRAIN initiative. The project will make use of a technique called radiogenetics that combines the use of radio waves or magnetic fields with nanoparticles to turn neurons on or off.

Neuroscientists use snail research to help explain “chemo brain”

October 8, 2014 12:00 pm | News | Comments

It is estimated that as many as half of patients taking cancer drugs experience a decrease in mental sharpness, but what causes “chemo brain” has eluded scientists. In the study involving a sea snail that shares many of the same memory mechanisms as humans and a drug used to treat cancer, scientists in Texas identified memory mechanisms blocked by the drug. Then, they were able to counteract the mechanisms by administering another agent.

“Bellhops” in cell walls can double as hormones

October 8, 2014 9:29 am | by SLAC Office of Communications | Videos | Comments

Researchers have discovered that some common messenger molecules in human cells double as hormones when bound to a protein that interacts with DNA. The finding could bring to light a class of previously unknown hormones and lead to new ways to target diseases—including cancers and a host of hormone-related disorders.

Getting metabolism right

October 8, 2014 7:59 am | by Larry Hardesty, MIT News Office | News | Comments

Metabolic networks are mathematical models of every possible sequence of chemical reactions available to an organ or organism, and they’re used to design microbes for manufacturing processes or to study disease. Based on both genetic analysis and empirical study, they can take years to assemble. Unfortunately, a new analytic tool suggests that many of those models may be wrong.

DNA linked to how much coffee you drink

October 7, 2014 2:15 pm | by Malcolm Ritter, AP Science Writer | News | Comments

Scientists have long known that your DNA influences how much java you consume. Now a huge study has identified some genes that may play a role. Their apparent effect is quite small. But variations in such genes may modify coffee's effect on a person's health, and so genetic research may help scientists explore that.

Researchers demonstrate how direct fluid flow influences neuron growth

October 7, 2014 2:11 pm | News | Comments

Axons are the shafts of neurons, on the tips of which connections are made with other neurons or cells. In a new study in Texas, researchers were able to use microfluidic stimulations to change the path of an axon at an angle of up to 90 degrees. The publication adds insight to the long accepted idea that chemical cues are primarily responsible for axonal pathfinding during human development and nervous system regeneration.

Green tea-based “missiles” kill cancer cells more effectively

October 7, 2014 9:47 am | News | Comments

Green tea has long been known for its anti-oxidant, anti-cancer, anti-aging and anti-microbial properties. A group of researchers from the Institute of Bioengineering and Nanotechnology in Singapore has taken the health benefits of green tea to the next level by using one of its ingredients, the antioxidant epigallocatechin gallate, to develop a drug delivery system that kills cancer cells more efficiently.

Three win medicine Nobel for discovering brain's GPS

October 7, 2014 9:28 am | by Karl Ritter and Jill Lawless, Associated Press | News | Comments

A U.S.-British scientist and a Norwegian husband-and-wife research team won the Nobel Prize in medicine for discovering the brain's navigation system—the inner GPS that helps us find our way in the world—a revelation that could lead to advances in diagnosing Alzheimer's. The research by John O'Keefe, May-Britt Moser and Edvard Moser represents a "paradigm shift" in neuroscience that could help researchers understand Alzheimer's disease.

Validation: Recognizing A Problem With Real-Time PCR Kits

October 7, 2014 7:49 am | by Keith Cockrum, Bio-Rad Laboratories | Bio-Rad Laboratories | Articles | Comments

Life Science researchers have become ever-more dependent on the industry for “kits” that are intended to execute research processes in the laboratory flawlessly. In recognition of this expectation, kit manufacturers now market nearly every product as “guaranteed” or “validated.” This practice has led the research community to feel secure that the products will perform as advertised.

Liquid DNA behind virus attacks

October 6, 2014 11:48 am | News | Comments

According to two recent studies, viruses can convert their DNA from solid to fluid form, explaining how viruses manage to eject DNA into the cells of their victims. The researchers in one study, which focused on herpes infections, say the discovery was surprising: No one was previously aware of the “phase transition” from solid to fluid form in virus DNA.

A glimpse into the 3-D brain

October 6, 2014 11:39 am | News | Comments

People who wish to know how memory works are forced to take a glimpse into the brain. They can now do so without bloodshed: Researchers have developed a new method for creating 3-D models of memory-relevant brain structures. The approach is unique because it enables automatic calculation of the neural interconnections in the brain on the basis of their position inside the space and their projection directions.

“Programmable” antibiotic uses enzyme to attack drug-resistant microbes

October 6, 2014 8:47 am | News | Comments

Microbes populating the human body have good, bad and mostly mysterious implications for our health. But when something goes wrong, we use the brute force of traditional antibiotics, which wipe out everything at once. Researchers at Rockefeller Univ. have developed a more subtle approach that uses the bacterial enzyme known as Cas9 to target a particular sequence of DNA, cutting that up but leaving more innocent microbes alone.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading